Churchill Downs Stock Price, News & Analysis (NASDAQ:CHDN)

8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Churchill Downs in the last year. There are currently 1 hold rating and 7 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" CHDN shares.
View CHDN analyst ratings or view top-rated stocks.

8 analysts have issued 12-month price objectives for Churchill Downs' shares. Their CHDN share price targets range from $121.50 to $148.00. On average, they predict the company's share price to reach $139.81 in the next twelve months. This suggests a possible upside of 21.3% from the stock's current price.
View analysts price targets for CHDN or view top-rated stocks among Wall Street analysts.

Churchill Downs' stock was trading at $105.7150 at the beginning of 2023. Since then, CHDN stock has increased by 9.0% and is now trading at $115.28.
View the best growth stocks for 2023 here.

The company is scheduled to release its next quarterly earnings announcement on Wednesday, February 28th 2024.
View our CHDN earnings forecast.

Churchill Downs Incorporated (NASDAQ:CHDN) announced its quarterly earnings data on Wednesday, October, 25th. The company reported $0.87 EPS for the quarter, beating the consensus estimate of $0.84 by $0.03. The company earned $572.50 million during the quarter, compared to analysts' expectations of $568.55 million. Churchill Downs had a net margin of 15.15% and a trailing twelve-month return on equity of 49.33%. The business's revenue for the quarter was up 49.4% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.81 EPS.

Churchill Downs declared an annual dividend on Wednesday, November 29th. Shareholders of record on Friday, December 1st will be paid a dividend of $0.382 per share on Friday, January 5th. This represents a yield of 0.35%. The ex-dividend date is Thursday, November 30th. This is a positive change from the stock's previous annual dividend of $0.36.
Read our dividend analysis for CHDN.

Churchill Downs (NASDAQ:CHDN) pays an annual dividend of $0.36 per share and currently has a dividend yield of 0.30%. The company has been increasing its dividend for 13 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio is 7.64%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, CHDN will have a dividend payout ratio of 6.13% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for CHDN.

ETFs with the largest weight of Churchill Downs (NASDAQ:CHDN) stock in their portfolio include Roundhill Sports Betting & iGaming ETF (BETZ), VanEck Gaming ETF (BJK), Invesco Leisure and Entertainment ETF (PEJ), B.A.D. Etf (BAD), Corbett Road Tactical Opportunity ETF (OPPX), Fidelity Small-Mid Cap Opportunities ETF (FSMO), Direxion Daily Travel & Vacation Bull 2X Shares (OOTO) and ALPS Global Travel Beneficiaries ETF (JRNY).

Churchill Downs's stock split on Monday, May 22nd 2023. The 2-1 split was announced on Tuesday, April 25th 2023. The newly created shares were distributed to shareholders after the market closes on Friday, May 19th 2023. An investor that had 100 shares of stock prior to the split would have 200 shares after the split.

16 employees have rated Churchill Downs Chief Executive Officer Bill Carstanjen on Glassdoor.com. Bill Carstanjen has an approval rating of 100% among the company's employees. This puts Bill Carstanjen in the top 10% of approval ratings compared to other CEOs of publicly-traded companies. 51.0% of employees surveyed would recommend working at Churchill Downs to a friend.

Based on aggregate information from My MarketBeat watchlists, some companies that other Churchill Downs investors own include NVIDIA (NVDA), Marvell Technology (MRVL), Alibaba Group (BABA), Intuitive Surgical (ISRG), Block (SQ), Baidu (BIDU), JD.com (JD), Boeing (BA), CRISPR Therapeutics (CRSP) and Teladoc Health (TDOC).

Churchill Downs' stock is owned by many different retail and institutional investors. Top institutional shareholders include FMR LLC (8.55%), Schroder Investment Management Group (2.35%), London Co. of Virginia (2.28%), Ameriprise Financial Inc. (1.46%), Brown Advisory Inc. (0.99%) and Bank of New York Mellon Corp (0.89%). Insiders that own company stock include Austin W Miller, Austin W Miller and William E Mudd.
View institutional ownership trends.

Shares of CHDN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.